Skip to main content
Top
Published in: Journal of Cancer Survivorship 1/2018

01-02-2018

Body mass index (BMI), postoperative appearance satisfaction, and sexual function in breast cancer survivorship

Authors: K. E. Rojas, N. Matthews, C. Raker, M. A. Clark, M. Onstad, A. Stuckey, J. Gass

Published in: Journal of Cancer Survivorship | Issue 1/2018

Login to get access

Abstract

Purpose

We sought to explore the correlation between BMI and postoperative sexual function, body image, and breast-specific sensuality before and after breast cancer surgery.

Methods

A cross-sectional survey of patients at least 1 year from surgery employed the Female Sexual Function Index (FSFI) and investigator-generated questions. Patients who underwent lumpectomy (L), mastectomy (M), and mastectomy with reconstruction (MR) were compared across three BMI groups: normal weight, overweight, and obese.

Results

Two hundred fifty-five patients underwent lumpectomy (L, n = 174), mastectomy (M, n = 22), or mastectomy with reconstruction (MR, n = 59). Median age was 57 (range 30–93) and median BMI was 28 (range 19–45). Obese and overweight women reported more appearance dissatisfaction (18.1 and 13.0%) than normal weight women (4.1%) (p = 0.01). Lower satisfaction was associated with increasing BMI within the MR group (p = 0.05). The obese group’s median FSFI score met criteria for sexual dysfunction (25.90, range 11.30–33.10). More overweight women reported their chest played an important role in intimacy before and after surgery, but a postoperative decline in the importance of this role was observed in all groups.

Conclusions

Greater post-treatment BMI is inversely related to postoperative appearance satisfaction, particularly in those undergoing mastectomy with reconstruction. The role of the breast in intimacy is greatest in overweight women, but decreases postoperatively in all BMI groups.

Implications for cancer survivors

Postoperative appearance satisfaction and sexual function seems to be correlated to post-treatment BMI, which highlights the need to encourage perioperative weight management for improved survivorship outcomes.
Literature
1.
go back to reference Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Female Breast Cancer, National Cancer Institute, DCCPS, Surveillance Research Program. www.seer.cancer.gov. Accessed 1 Oct 2016. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Female Breast Cancer, National Cancer Institute, DCCPS, Surveillance Research Program. www.​seer.​cancer.​gov. Accessed 1 Oct 2016.
3.
go back to reference Hewitt M, Greenfield S, Stovall E, editors. Institute of Medicine and National Research Council. From cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2006. 10.17226/11468. Accessed April 1 2017 Hewitt M, Greenfield S, Stovall E, editors. Institute of Medicine and National Research Council. From cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2006. 10.​17226/​11468. Accessed April 1 2017
4.
go back to reference Amichetti M, Caffo O. Quality of life in patients with early stage breast carcinoma treated with conservation surgery and radiotherapy: an Italian monoinstitutional study. Tumori Journal. 2001;87:78–84. Amichetti M, Caffo O. Quality of life in patients with early stage breast carcinoma treated with conservation surgery and radiotherapy: an Italian monoinstitutional study. Tumori Journal. 2001;87:78–84.
5.
go back to reference Gorisek B, Krajnc P, Krajnc I. Quality of life and the effect on social status among Slovenian women after breast cancer treatment. J Int Med Res. 2009;37:557–66.CrossRefPubMed Gorisek B, Krajnc P, Krajnc I. Quality of life and the effect on social status among Slovenian women after breast cancer treatment. J Int Med Res. 2009;37:557–66.CrossRefPubMed
6.
go back to reference Brandberg Y, Sandelin K, Erikson S, et al. Psychological reactions, quality of life, and body image after bilateral pro-phylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol. 2008;26:3943–9.CrossRefPubMed Brandberg Y, Sandelin K, Erikson S, et al. Psychological reactions, quality of life, and body image after bilateral pro-phylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol. 2008;26:3943–9.CrossRefPubMed
7.
go back to reference Klaeson K, Berterö C. Sexual identity following breast cancer treatments in premenopausal women. Int J Qual Stud Health Well-being. 2008;3:185–92.CrossRef Klaeson K, Berterö C. Sexual identity following breast cancer treatments in premenopausal women. Int J Qual Stud Health Well-being. 2008;3:185–92.CrossRef
8.
go back to reference Krueger D, Cash T, Pruzinsky T. Psychodynamic perspectives on body image. In: Body image: a handbook of theory, research, and clinical practice. New York: Guilford Press; 2004. p. 30–7. Krueger D, Cash T, Pruzinsky T. Psychodynamic perspectives on body image. In: Body image: a handbook of theory, research, and clinical practice. New York: Guilford Press; 2004. p. 30–7.
11.
go back to reference Raggio G, Butryn M, Arigo D, et al. Prevalence and correlates of sexual morbidity in long-term breast cancer survivors. Psychol Health. 2014;29:632–50.CrossRefPubMedPubMedCentral Raggio G, Butryn M, Arigo D, et al. Prevalence and correlates of sexual morbidity in long-term breast cancer survivors. Psychol Health. 2014;29:632–50.CrossRefPubMedPubMedCentral
12.
go back to reference Hoyt W, Kogan L. Satisfaction with body image and peer relationships for males and females in a college environment. Sex Roles. 2001;45:199–215.CrossRef Hoyt W, Kogan L. Satisfaction with body image and peer relationships for males and females in a college environment. Sex Roles. 2001;45:199–215.CrossRef
13.
go back to reference Pujols Y, Meston C, Brooke S. The association between sexual satisfaction and body image in women. J Sex Med. 2010;7:905–16.CrossRefPubMed Pujols Y, Meston C, Brooke S. The association between sexual satisfaction and body image in women. J Sex Med. 2010;7:905–16.CrossRefPubMed
15.
go back to reference Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.CrossRefPubMed Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.CrossRefPubMed
16.
go back to reference Baser R, Li Y, Carter J. Psychometric validation of the female sexual function index (FSFI) in cancer survivors. Cancer. 2012;118(18):4606–18.CrossRefPubMed Baser R, Li Y, Carter J. Psychometric validation of the female sexual function index (FSFI) in cancer survivors. Cancer. 2012;118(18):4606–18.CrossRefPubMed
17.
go back to reference Mohammedi J. The female sexual function index (FSFI): validation of the Iranian version. Payesh. 2008;7(3):269–78. Mohammedi J. The female sexual function index (FSFI): validation of the Iranian version. Payesh. 2008;7(3):269–78.
18.
go back to reference Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31:1–20.CrossRefPubMed Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31:1–20.CrossRefPubMed
19.
go back to reference Rowland J, Meyerowitz B, Crespi C, et al. Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention. Breast Cancer Res Treat. 2009;118(1):99–111.CrossRefPubMedPubMedCentral Rowland J, Meyerowitz B, Crespi C, et al. Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention. Breast Cancer Res Treat. 2009;118(1):99–111.CrossRefPubMedPubMedCentral
20.
go back to reference Schover L, Baum G, Fuson L, et al. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors. J Sex Med. 2014;11:3102–11.CrossRefPubMedPubMedCentral Schover L, Baum G, Fuson L, et al. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors. J Sex Med. 2014;11:3102–11.CrossRefPubMedPubMedCentral
21.
go back to reference Acea Nebril B, Cereijo Garea C, Garcia Novoa A. Cosmetic sequelae after oncoplastic surgery of the breast: classification and factors for prevention. Cir Esp. 2015;2:75–83.CrossRef Acea Nebril B, Cereijo Garea C, Garcia Novoa A. Cosmetic sequelae after oncoplastic surgery of the breast: classification and factors for prevention. Cir Esp. 2015;2:75–83.CrossRef
22.
go back to reference Tong W, Baumann D, Villa M, Mittendorg E, Liu J, Robb G, et al. Obese women experience fewer complications after oncoplastic breast repair following partial mastectomy than after immediate total breast reconstruction. Plast Recon Surg. 2016;137(3):777–91.CrossRef Tong W, Baumann D, Villa M, Mittendorg E, Liu J, Robb G, et al. Obese women experience fewer complications after oncoplastic breast repair following partial mastectomy than after immediate total breast reconstruction. Plast Recon Surg. 2016;137(3):777–91.CrossRef
Metadata
Title
Body mass index (BMI), postoperative appearance satisfaction, and sexual function in breast cancer survivorship
Authors
K. E. Rojas
N. Matthews
C. Raker
M. A. Clark
M. Onstad
A. Stuckey
J. Gass
Publication date
01-02-2018
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 1/2018
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-017-0651-y

Other articles of this Issue 1/2018

Journal of Cancer Survivorship 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine